Learning Objectives:

Head and Neck

1.  Understand the role of pembrolizumab in first line treatment of advanced head & neck cancer patients with metastatic or unresectable disease.

2.  Consider the options of surgical vs. radiation-based approaches to treatment of HPV-related oropharyngeal cancer.


1.  Learn about immune therapy in lung cancer.

2.  Discuss side effects of immune therapy in lung cancer.

3.  Review options for other therapies in lung cancer.

Session date: 
08/29/2019 - 8:00am to 9:15am CDT
Evanston Hospital, Room G870
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Bruce Brockstein, M.D. & Nick Campbell, M.D.